Beyond the DHT Blocker
The Trichological Art of Preserving the Follicle
Mario Zunino's Esterel, BioMethod, and the Philosophy of Comprehensive Hair and Scalp Care
Scientific Classification: Trichology • Follicular Biology • Androgen Signaling • Sebaceous Physiology • Scalp Ecology Conservatory Classification: Preservation • Cleansing • Scalp Renewal • Follicular Support • Continuity
I. Opening Manuscript — The Follicle Does Not Live Alone
After a lifetime of working with hair, I have come to believe that one of the greatest mistakes in hair care is to reduce a complex living system to a single cause.
We see thinning and immediately think of DHT.
We see shedding and immediately search for a stimulant.
We see an oily scalp and reach for a stronger shampoo.
But the follicle does not exist in isolation.
It lives within skin. It is influenced by hormones, cellular signaling, inflammation, metabolism, and the changing physiology of the individual.
And above the skin emerges a delicate fiber that must endure washing, brushing, heat, color, sunlight, and time.
To care for hair intelligently, we must understand all three: the person, the scalp, and the follicle.
This was an important part of the trichological philosophy I encountered through Mario Zunino's Esterel tradition and later carried into the development of BioMethod.
Not simply to intervene.
To understand the environment in which intervention must work.
II. The Limitation of a Single Target
Dihydrotestosterone, or DHT, is produced when the enzyme 5-alpha-reductase converts testosterone into a more potent androgen.
In genetically susceptible follicles, androgen signaling can contribute to progressive miniaturization.
A follicle that once produced a substantial terminal hair may gradually produce a finer, shorter fiber.
Reducing androgen activity can therefore be an important therapeutic strategy in appropriately selected patients.
But the biological story does not end there.
A woman with patterned thinning may also have seborrheic dermatitis, iron deficiency, telogen shedding, hair-fiber damage, or another condition requiring attention.
A DHT-directed treatment does not automatically resolve those separate problems.
Nor should we assume that every woman with patterned loss has excessive circulating DHT.
The objective of comprehensive care is not to reject a targeted treatment.
It is to recognize what that treatment does—and what it does not do.
III. DHT Is Not a Deposit to Be Washed Away
There is an important distinction between removing material from the scalp surface and modifying hormonal activity within the follicle.
Sebum, sweat residues, dead skin cells, cosmetic deposits, and environmental particles can accumulate on the scalp and hair.
Appropriate cleansing can remove these materials.
DHT is different.
It is a hormone produced and metabolized within living tissues. It participates in receptor-mediated signaling.
It is not simply a layer of residue that can be washed from the follicle through detoxification.
For this reason, a scalp treatment should not be described as removing excessive follicular DHT unless that particular mechanism has been demonstrated through suitable research.
The more scientifically accurate distinction is this:
**Cleansing addresses removable surface material. Antiandrogen treatment addresses hormone-related pathways. Hair-growth treatment may act through additional biological mechanisms.**
These interventions can have different purposes.
Their value depends upon the condition being treated.
IV. Mario Zunino and the Esterel Philosophy
The Esterel tradition represents an important chapter in the professional history of the House.
Mario Zunino approached hair and scalp care as a discipline requiring observation, preparation, and continuing attention to the condition of the scalp.
Rather than treating the visible fiber as the entire subject, the trichological approach emphasized the living environment from which that fiber emerges.
This philosophy influenced the way I came to understand professional treatment.
A scalp should be examined.
Its oiliness, scaling, sensitivity, and condition should be considered.
The hair fiber should be evaluated independently.
And treatment should follow an informed sequence rather than an indiscriminate application of products.
The historical Esterel methods and their proposed mechanisms deserve preservation as part of our professional heritage.
At the same time, the House must distinguish historical clinical philosophy from claims established by modern controlled studies.
A treatment tradition can possess practical wisdom without every proposed mechanism having been scientifically confirmed.
That distinction honors the legacy rather than diminishing it.
V. BioMethod — Continuity as a Treatment Philosophy
BioMethod continues the House's emphasis on treating the scalp and hair fiber as related but distinct environments.
The scalp requires attention to cleansing, comfort, and its particular biological condition.
The hair fiber requires attention to structure, moisture management, surface protection, and resistance to avoidable damage.
A personalized regimen may therefore involve more than one product because more than one need is being addressed.
An oily scalp with fragile, chemically treated lengths is not the same as a dry, comfortable scalp with healthy hair fiber.
A guest experiencing shedding after significant weight loss presents different questions from one experiencing progressive follicular miniaturization.
The purpose of a comprehensive regimen is to respond to those differences.
It is not to assume that every guest requires every product.
Nor should the number of steps be mistaken for proof of effectiveness.
The value of a system lies in whether its components have a clear purpose, are appropriate for the individual, and produce meaningful, observable benefits.
VI. The Scalp's Living Ecology
Sebum is a normal product of the sebaceous glands.
It contributes to the lipid environment of the skin and hair.
Sweat participates in thermoregulation.
Neither substance is inherently a toxin.
Problems may arise when oil production, microbial activity, skin-barrier function, inflammation, or cleansing practices become imbalanced.
In seborrheic dermatitis, for example, interactions involving sebum, Malassezia yeasts, and the host inflammatory response can contribute to scaling, itching, redness, and discomfort.
This is a genuine biological condition, not merely evidence of poor hygiene.
Its management may require antifungal or anti-inflammatory treatment rather than cosmetic cleansing alone.
The trichological responsibility is to distinguish normal physiology from a condition requiring intervention.
We should not attempt to eliminate sebum.
We should seek to understand when its surrounding biological environment has become disturbed.
VII. When There Is Less Hair to Cover the Scalp
There is a practical observation worth exploring.
As visible hair density decreases, the scalp may become more exposed to sunlight, heat, and the environment.
Oiliness, sweat, and scaling may also become more noticeable because fewer fibers are present to distribute or conceal surface material.
A woman who once experienced a comfortable scalp may become increasingly conscious of its shine, perspiration, or sensitivity.
But reduced hair density does not, by itself, establish that the sebaceous glands have begun producing excessive oil or that sweat has become a cause of additional follicular loss.
The relationship deserves careful assessment.
Where seborrheic dermatitis or another inflammatory condition coexists with patterned hair loss, treating the scalp disorder can improve comfort and address an additional source of inflammation.
Whether that treatment also changes the course of androgen-related miniaturization is a separate question requiring evidence.
The House should never confuse coexistence with causation.
VIII. Decongestion — What Are We Actually Treating?
The word *decongestion* has a long history in professional scalp-care language.
Within a modern scientific manuscript, however, it needs a precise meaning.
If we mean removing accumulated sebum, scale, sweat residue, or styling-product deposits, we are describing cleansing and surface management.
If we mean reducing inflammation, treating dermatitis, or restoring a disturbed skin barrier, we are describing specific biological treatment objectives.
If we mean reversing follicular miniaturization, we are describing a different outcome altogether.
These processes must not be treated as synonyms.
A clean scalp is not necessarily a scalp free from inflammatory disease.
A comfortable scalp is not necessarily a scalp whose miniaturized follicles have recovered.
And a reduction in visible oil does not demonstrate a reduction in follicular DHT.
Precision protects the guest from promises that exceed the evidence.
IX. Rejuvenation Requires More Than a Beautiful Scalp
One of the most important distinctions in trichology is between improving the condition of the scalp and demonstrating new hair growth.
A scalp treatment may reduce flaking or discomfort.
A conditioner may reduce friction and breakage.
A professional regimen may improve the appearance and manageability of existing hair.
These are meaningful outcomes.
But they should not be confused with increased terminal-hair density, reversal of miniaturization, or regeneration of follicles.
For female-pattern hair loss, topical minoxidil has established evidence for improving hair growth in some women. Selected patients may also benefit from clinician-directed treatments involving androgen pathways or other approaches.
Such treatments do not replace the need to address coexisting scalp disorders or protect fragile hair fibers.
Equally, a comprehensive cosmetic regimen does not automatically replace evidence-based medical treatment.
The intelligent approach recognizes that different interventions may solve different problems.
X. The Discipline of Sequence
The House's treatment philosophy can be understood through a sequence of decisions.
**First: Identify the loss.**
Is the guest experiencing diffuse shedding, progressive miniaturization, hair-fiber breakage, or a combination?
**Second: Examine the scalp.**
Is it comfortable, oily, flaky, inflamed, sensitive, or affected by a recognizable disorder?
**Third: Consider the individual's biology.**
Have hormones, medications, nutrition, illness, or major life changes influenced the condition?
**Fourth: Establish the treatment objectives.**
Are we trying to improve scalp comfort, control inflammation, reduce breakage, preserve existing hair, or treat progressive follicular miniaturization?
**Fifth: Choose the appropriate interventions.**
Medical treatments, scalp-care products, hair-fiber protection, and lifestyle measures should be selected according to the needs they can reasonably address.
**Sixth: Observe and reassess.**
Progress should be judged by relevant outcomes, not by the complexity or price of the regimen.
This is the difference between a collection of products and a disciplined system of care.
XI. The Responsibility of the Trichologist
A guest who has begun losing hair is often vulnerable.
She may be frightened by the amount of hair in the shower.
She may have watched her central part widen over several years.
She may have tried countless products, each promising to solve what the previous one could not.
The temptation to offer certainty is understandable.
But certainty without evidence is not wisdom.
A responsible trichological consultation recognizes what can be observed, what remains uncertain, and when a dermatologist or another medical professional should become involved.
The trichologist's value is not measured by the number of products recommended.
It is measured by the quality of the inquiry, the appropriateness of the care, and the honesty of the expectations established.
XII. The House Perspective — The Whole Living Environment
Mario Zunino's influence taught me to look beyond the visible strand.
My work with BioMethod deepened that conviction.
I came to understand that the hair fiber, the scalp, and the biological processes beneath the surface deserve individual attention.
A guest may require a targeted medical treatment for follicular miniaturization while also benefiting from appropriate scalp cleansing and hair-fiber protection.
Another may require investigation of diffuse shedding without any indication for androgen-directed therapy.
Another may simply need a more intelligent approach to managing oil, scale, or breakage.
The purpose of trichology is not to make every treatment more complicated.
It is to make every treatment more appropriate.
The greatest luxury we can offer is not an elaborate regimen.
It is care that has been thoughtfully chosen.
XIII. Closing Manuscript — Beyond a Single Answer
The living follicle belongs to a larger biological world.
It is influenced by the person, the skin, the hormones, the immune system, and time.
No single explanation accounts for every form of hair loss.
No single product answers every need.
And no tradition, however meaningful, should be protected from scientific examination.
The wisdom of comprehensive trichology lies in understanding what each intervention can accomplish, what it cannot, and when several carefully selected approaches may belong together.
After a lifetime devoted to the study of beauty, I have come to believe that the finest care is not the care that promises everything.
It is the care that understands precisely what deserves attention.
**The follicle is part of a living system. Our responsibility is to care for that system with knowledge, restraint, and respect.**
— Shann Christen
Related Conservatory Papers
Paper No. 001 — Saw Palmetto: The First Guardian
Paper No. 158 — Sebum
Paper No. 169 — Sweat, Odor & Scalp Ecology
Paper No. 172 — Differential Inquiry: The Question Before the Answer
Paper No. 173 — When the Hair Begins to Fall
Paper No. 174 — Female-Pattern Hair Loss: The Pattern Beneath the Loss
Scientific References
Carmina E, et al. Female Pattern Hair Loss and Androgen Excess. Journal of Clinical Endocrinology & Metabolism. 2019;104(7):2875–2891. https://pubmed.ncbi.nlm.nih.gov/30785992/
Fabbrocini G, et al. Female Pattern Hair Loss: A Clinical, Pathophysiologic, and Therapeutic Review. International Journal of Women's Dermatology. 2018;4(4):203–211. https://pubmed.ncbi.nlm.nih.gov/30627618/
van Zuuren EJ, et al. Interventions for Female Pattern Hair Loss. Cochrane Database of Systematic Reviews. 2016. https://www.cochrane.org/evidence/CD007628_treatments-female-pattern-hair-loss
Adalsteinsson JA, et al. Scalp Seborrheic Dermatitis: What We Know So Far. Skin Appendage Disorders. 2023. https://pubmed.ncbi.nlm.nih.gov/37325288/
Vañó-Galván S, et al. A Comprehensive Literature Review and an International Expert Consensus on the Management of Scalp Seborrheic Dermatitis in Adults. European Journal of Dermatology. 2024. https://pubmed.ncbi.nlm.nih.gov/38919137/
Antiandrogen Therapy for the Treatment of Female Pattern Hair Loss: A Clinical Review of Current and Emerging Therapies. Journal of the American Academy of Dermatology. 2025. https://pubmed.ncbi.nlm.nih.gov/40345536/
House Principle
Biology before intervention. Preservation before correction. Understanding before recommendation.
Nature Perfected Through Science.